The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
X‐chromosome inactivation in female patients with Fabry disease
Abstract
Fabry disease (FD) is an X‐linked genetic disorder caused by the deficient activity of lysosomal α‐galactosidase (α‐Gal). While males are usually severely affected, clinical presentation in female patients may be more variable ranging from asymptomatic to, occasionally, as severely affected as male patients. The aim of this study was to evaluate the existence of skewed X‐chromosome inactivation (XCI) in females with FD, its concordance between tissues, and its contribution to the phenotype. Fifty‐six females with FD were enrolled. Clinical and biological work‐up included two global scores [Mainz Severity Score Index (MSSI) and DS3], cardiac magnetic resonance imaging, measured glomerular filtration rate, and measurement of α‐Gal activity. XCI was analyzed in four tissues using DNA methylation studies. Skewed XCI was found in 29% of the study population. A correlation was found in XCI patterns between blood and the other analyzed tissues although some punctual variability was detected. Significant differences in residual α‐Gal levels, severity scores, progression of cardiomyopathy and deterioration of kidney function, depending on the direction and degree of skewing of XCI were evidenced. XCI significantly impacts the phenotype and natural history of FD in females.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Action in the X-chromosome of the Mouse (Mus musculus L.)
LYON, M. F. (1961) · Nature · doi:10.1038/190372a0 · Cited by 3,978
Allen, R. C., Zoghbi, H. Y., Moseley, A., Rosenblatt, H. M., & Belmont, J. W. (1992) · PubMed · Cited by 1,697
Signals from the lysosome: a control centre for cellular clearance and energy metabolism
Settembre, C., Fraldi, A., Medina, D. L., & Ballabio, A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3565 · Cited by 1,697
Germain, D. P. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-30 · Cited by 1,198
Self-citationMacDermot, K. D., Holmes, A., & Miners, A. H. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.11.769 · Cited by 681
α-Galactosidase A deficiency. Fabry disease
Desnick, R. J. (2001) · Cited by 605
Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry
Wilcox, W. R., Oliveira, J. P., Hopkin, R. J., Ortiz, A., Banikazemi, M., Feldt-Rasmussen, U., Sims, K., Waldek, S., Pastores, G. M., Lee, P., et al. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.09.013 · Cited by 544
Self-citationBeutler, E., Yeh, M., & Fairbanks, V. F. (1962) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.48.1.9 · Cited by 503
Age- and tissue-specific variation of X chromosome inactivation ratios in normal women
Sharp, A., Robinson, D., & Jacobs, P. (2000) · Human Genetics · doi:10.1007/s004390000382 · Cited by 404
Schiffmann, R., Warnock, D. G., Banikazemi, M., Bultas, J., Linthorst, G. E., Packman, S., Sorensen, S. A., Wilcox, W. R., & Desnick, R. J. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp031 · Cited by 368
X Chromosome–Inactivation Patterns of 1,005 Phenotypically Unaffected Females
Amos-Landgraf, J. M., Cottle, A., Plenge, R. M., Friez, M., Schwartz, C. E., Longshore, J., & Willard, H. F. (2006) · The American Journal of Human Genetics · doi:10.1086/507565 · Cited by 342
Prevalence of Fabry Disease in a Cohort of 508 Unrelated Patients With Hypertrophic Cardiomyopathy
Monserrat, L., Gimeno-Blanes, J. R., Marín, F., Hermida-Prieto, M., García-Honrubia, A., Pérez, I., Fernández, X., de Nicolas, R., de la Morena, G., Payá, E., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.062 · Cited by 291
Anderson–Fabry disease: Clinical manifestations of disease in female heterozygotes
Whybra, C., Kampmann, C., Willers, I., Davies, J., Winchester, B., Kriegsmann, J., Brühl, K., Gal, A., Bunge, S., & Beck, M. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1012993305223 · Cited by 276
Whybra, C., Kampmann, C., Krummenauer, F., Ries, M., Mengel, E., Miebach, E., Baehner, F., Kim, K., Bajbouj, M., Schwarting, A., et al. (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00219.x · Cited by 266
Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease.
Eng, C. M., Resnick‐Silverman, L., Niehaus, D. J., Astrin, K. H., & Desnick, R. J. (1993) · PubMed · Cited by 220
Mayes, J. S., Scheerer, J. B., Sifers, R. N., & Donaldson, M. L. (1981) · Clinica Chimica Acta · doi:10.1016/0009-8981(81)90384-3 · Cited by 218
Genetic control of X inactivation and processes leading to X-inactivation skewing.
Belmont, J. W. (1996) · PubMed · Cited by 194
Comparison of X-chromosome inactivation patterns in multiple tissues from human females
Bittel, D. C., Theodoro, M. F., Kibiryeva, N., Fischer, W., Talebizadeh, Z., & Butler, M. G. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.055244 · Cited by 191
Inheritance of most X‐linked traits is not dominant or recessive, just X‐linked
Dobyns, W. B., Filauro, A., Tomson, B. N., Chan, A. S., Ho, A. W., Ting, N. T., Oosterwijk, J. C., & Ober, C. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30123 · Cited by 183
Early renal changes in hemizygous and heterozygous patients with Fabry's disease
Gübler, M.-C., Lenoir, G., Grünfeld, J., Ulmann, A., Droz, D., Habib, R., Naizot, C., Adafer, E., & Grandhomme, C. (1978) · Kidney International · doi:10.1038/ki.1978.32 · Cited by 182
Tissue specificity of X-chromosome inactivation patterns
Gale, R., Wheadon, H., Boulos, P., & Linch, D. (1994) · Blood · doi:10.1182/blood.v83.10.2899.2899 · Cited by 179
Dobrovolny, R., Dvorakova, L., Ledvinova, J., Magage, S., Bultas, J., Lubanda, J. C., Elleder, M., Karetova, D., Pavlikova, M., & Hrebicek, M. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0656-2 · Cited by 172
Heritability of X chromosome--inactivation phenotype in a large family.
Naumova, A. K., Plenge, R. M., Bird, L. M., Leppert, M., Morgan, K., Willard, H. F., & Sapienza, C. (1996) · PubMed Central · Cited by 168
Puck, J. M., Nussbaum, R. L., & Conley, M. E. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112967 · Cited by 158
X-chromosome inactivation and human genetic disease
Lyon, M. F. (2002) · Acta Paediatrica · doi:10.1111/j.1651-2227.2002.tb03120.x · Cited by 154
Shabbeer, J., Yasuda, M., Benson, S. D., & Desnick, R. J. (2006) · Human Genomics · doi:10.1186/1479-7364-2-5-297 · Cited by 144
The causes and consequences of random and non‐random X chromosome inactivation in humans
Brown, C. J., & Robinson, W. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.580504.x · Cited by 136
Sakuraba, H., Oshima, A., Fukuhara, Y., Shimmoto, M., Nagao, Y., Bishop, D. F., Desnick, R. J., & Suzuki, Y. (1990) · PubMed · Cited by 136
Pathogenic cascades in lysosomal disease—Why so complex?
Walkley, S. U. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-1040-5 · Cited by 136
A skewed view of X chromosome inactivation
Minks, J., Robinson, W. P., & Brown, C. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci34470 · Cited by 120
Disease manifestations and X inactivation in heterozygous females with Fabry disease
Maier, E. M., Osterrieder, S., Whybra, C., Ries, M., Gal, A., Beck, M., Roscher, A. A., & Muntau, A. C. (2006) · Acta Paediatrica · doi:10.1080/08035320600618809 · Cited by 119
Ishii, S., Sakuraba, H., & Suzuki, Y. (1992) · Human Genetics · doi:10.1007/bf00207037 · Cited by 103
Galactose Stabilizes Various Missense Mutants of α-Galactosidase in Fabry Disease
Okumiya, T., Ishii, S., Takenaka, T., Kase, R., Kamei, S., Sakuraba, H., & Suzuki, Y. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2416 · Cited by 101
Busque, L., Paquette, Y., Provost, S., Roy, D., Levine, R. L., Mollica, L. R., & Gilliland, D. G. (2009) · Blood · doi:10.1182/blood-2008-12-195677 · Cited by 85
Non-random X chromosome inactivation in mammalian cells
Migeon, B. R. (1998) · Cytogenetic and Genome Research · doi:10.1159/000014971 · Cited by 83
Mutation analysis in patients with the typical form of Anderson — Fabry disease
Davies, J. P., WINCHESTER, B. G., & Malcolm, S. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.7.1051 · Cited by 79
Germain, D. P., Shabbeer, J., Cotigny, S., & Desnick, R. J. (2002) · Molecular Medicine · doi:10.1007/bf03402156 · Cited by 78
Self-citationPORCNmutations in focal dermal hypoplasia: coping with lethality
Bornholdt, D., Oeffner, F., König, A., Happle, R., Alanay, Y., Ascherman, J. A., Benke, P. J., Boente, M. D. C., van der Burgt, I., Chassaing, N., et al. (2009) · Human Mutation · doi:10.1002/humu.20992 · Cited by 76
A validated disease severity scoring system for Fabry disease
Giannini, E. H., Mehta, A. B., Hilz, M. J., Beck, M., Bichet, D. G., Brady, R. O., West, M. L., Germain, D. P., Wanner, C., Waldek, S., et al. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.10.178 · Cited by 73
Self-citationThree New Loci for Determining X Chromosome Inactivation Patterns
Bertelsen, B., Tümer, Z., & Ravn, K. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2011.05.003 · Cited by 61
Prediction of response of mutated alpha-galactosidase A to a pharmacological chaperone
Shin, S. H., Kluepfel-Stahl, S., Cooney, A. M., Kaneski, C. R., Quirk, J. M., Schiffmann, R., Brady, R. O., & Murray, G. J. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32830500f4 · Cited by 43
Azofeifa, J., Cremer, M., & Waldherr, R. (1996) · Human Genetics · doi:10.1007/bf02185765 · Cited by 28
Guillén‐Navarro, E., Jiménez, R. D., Alcalde-Martín, C., Candela, R. C., Couce, M. L., Gómez, E. G., & Luengo, O. A. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-92 · Cited by 27
Wang, Z., Yan, A.-Z., Lin, Y., Xie, H., Zhou, C., & Lan, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057977 · Cited by 23
Disease manifestations and X inactivation in heterozygous females with Fabry disease
Maier, E. M., Osterrieder, S., Whybra, C., Ries, M., Gal, A., Beck, M., Roscher, A. A., & Muntau, A. C. (2006) · Acta Paediatrica · doi:10.1111/j.1651-2227.2006.tb02386.x · Cited by 15
Cited by
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Fabry disease revisited: Management and treatment recommendations for adult patients
Ortiz, A., Germain, D. P., Desnick, R. J., Politei, J., Mauer, M., Burlina, A., Eng, C., Hopkin, R. J., Laney, D., Linhart, A., et al. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.02.014 · Cited by 650
Self-citationCharacterization of Classical and Nonclassical Fabry Disease: A Multicenter Study
Arends, M., Wanner, C., Hughes, D., Mehta, A., Oder, D., Watkinson, O. T., Elliott, P. M., Linthorst, G. E., Wijburg, F. A., Biegstraaten, M., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016090964 · Cited by 416
Hughes, D. A., Nicholls, K., Shankar, S. P., Sunder-Plassmann, G., Koeller, D., Nedd, K., Vockley, G., Hamazaki, T., Lachmann, R., Ohashi, T., et al. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104178 · Cited by 386
Self-citationCardiac Involvement in Fabry Disease
Pieroni, M., Moon, J. C., Arbustini, E., Barriales-Villa, R., Camporeale, A., Vujkovac, A. C., Elliott, P. M., Hagege, A., Kuusisto, J., Linhart, A., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.12.024 · Cited by 340
Self-citation
Metadata
- Authors
- Echevarria, L., Benistan, K., Toussaint, A., Dubourg, O., Hagege, A. A., Eladari, D., Jabbour, F., Beldjord, C., De Mazancourt, P., & Germain, D. P.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2015-06-22
- Volume
- 89
- Issue
- 1
- Pages
- 44-54
- ISSN
- 0009-9163 (ISSN-L)
- 1399-0004
- OpenAlex
- W1934932849
- Cited by
- 424
- References
- 45
- FWCI
- 20.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.